NCT03662724View on ClinicalTrials.gov

Venetoclax Registry

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

November 1, 2021

Study Completion Date

November 1, 2025

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Venetoclax

Registry study observing clinical and biological characteristics of patients with acute myeloid leukemia who are treated with Venetoclax.

Trial Locations (1)

30625

RECRUITING

Medical School Hannover, Hanover

All Listed Sponsors
lead

Hannover Medical School

OTHER